| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-10 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0005 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |